Great Point Partners, LLC 13D and 13G filings for Context Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:33 pm Sale | 2024-12-31 | 13G | Context Therapeutics Inc. CNTX | Great Point Partners, LLC | 4,683,711 6.250% | -2,251,271 (-32.46%) | Filing |
| 2024-11-14 4:52 pm Sale | 2024-09-30 | 13G | Context Therapeutics Inc. CNTX | Great Point Partners, LLC | 6,934,982 9.250% | -484,373 (-6.53%) | Filing |
| 2024-06-05 10:45 am Purchase | 2024-05-31 | 13G | Context Therapeutics Inc. CNTX | Great Point Partners, LLC | 7,419,355 9.890% | 7,419,355 (New Position) | Filing |